About this trial
An inadequate amount of peri-implant soft tissue results in more plaque accumulation around the implants, peri-implant mucositis, marginal bone loss, mucosal recession, and/or attachment loss. In the literature, there are studies evaluating the application of injectable platelet-rich fibrin to the gingiva and oral mucosa around teeth, but injectable platelet-rich fibrin application around implants has not been encountered. This study aimed to evaluate the effect of subgingival and submucosal application of injectable platelet-rich fibrin on peri-implant soft tissue phenotype in patients with inadequate peri-implant soft tissue phenotype.The study will include 80 systemically healthy and non-smoking patients/implants older than 18 years of age with insufficient peri-implant keratinized mucosa width and mucosal thickness who applied to Kütahya University of Health Sciences, Faculty of Dentistry, Department of Periodontology. There are two study groups according to peri-implant mucosa phenotype: Thin phenotype and thick phenotype. All patients will undergo the same procedure of injectable platelet-rich fibrin application
Eligibility criteria
Qualifiers
be over 18 years old
The patient does not have any systemic disease
Patients who do not smoke or who smoke less than 10 cigarettes
Peri-implant keratinized mucosa width less than 2 mm
Disqualifiers
Being out of the defined age group
Any systematic contraindication for periodontal surgery
Patients who smoke more than 10 cigarettes per day
Patients with adequate peri-implant keratinized mucosa width and mucosal thickness
Trial design
Treatments tested in this trial
- Platelet rich fibrin